The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,200.00
Bid: 4,140.00
Ask: 4,300.00
Change: 40.00 (0.96%)
Spread: 160.00 (3.865%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Jun 2013 15:01

RNS Number : 3195H
North Atlantic Smlr Co Inv Tst PLC
18 June 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 MAY 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 February 2013 to 31 May 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 May 2013

3 months %

6 months %

1 year %

3 years %

5 years %

Diluted NAV*

1,749p

1.6

8.7

22.7

43.5

50.0

Mid-market price

1,440p 

3.3

17.6

55.7

70.8

41.9

Discount to diluted NAV *

17.7% 

Standard & Poor's 500 Composite Index **

1,073.0

7.4

21.3

26.2

43.2

51.9

Russell 2000 **

647.5

7.8

26.1

30.1

42.3

91.9

FTSE All-Share Index

5,090.8

5.0

15.3

30.1

44.1

35.2

US Dollar/Sterling exchange rate

1.5161

0.1

5.4

1.5

(4.4)

23.5

 

* Following the conversion of the Loan Stock, the performance is shown on the diluted NAV (excluding retained revenue for the period) only. The Board considers that this accurately reflects the underlying performance of the Company.

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's Convertible Unsecured Loan Stock 2013 ("the Loan Stock") was all either converted voluntarily by the Loan Stockholders themselves, or was then compulsorily converted by the Trustee of the Loan Stock and subsequently sold with the proceeds from that sale then being distributed rateably to Stockholders. Following this, the Company no longer has any Loan Stock.

 

There have been no material transactions during the quarter ended 31 May 2013.

 

Transaction in Own Shares

 

There have been no transactions in the Company's own shares during the quarter ended 31 May 2013.

 

 

TEN LARGEST INVESTMENTS AT 31 MAY 2013 Percentage of Portfolio

Gleeson (MJ) Group

UK Listed

11.0

US Treasury Bills

US Treasury Bills

10.5

Oryx International Growth Fund Limited *

UK Listed

9.6

Bionostics Holdings Limited

US Unquoted

8.8

Trident Private Equity Fund III LLP

UK Unquoted

7.8

Hampton Investment Properties Limited

UK Unquoted

5.1

Celsis AG

US Unquoted

4.7

Bioquell

UK Listed

3.4

Guinness Peat Group **

UK Listed

3.4

AssetCo PLC

UK Listed

3.3

% of total portfolio

67.6

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 MAY 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

10.1

9.6

19.7

Health Care, Equipment & Services

0.2

11.1

11.3

Construction & Materials

11.0

11.0

Treasury Bills

10.5

10.5

Manufacturing

8.8

8.8

Real Estate

7.5

0.4

7.9

General Financials

4.3

4.3

Support Services

1.3

2.6

3.9

Financial Services

3.4

3.4

Industrial Engineering

3.3

3.3

General Industrials

1.2

1.5

2.7

General Retailers

2.7

2.7

Transportation

2.6

2.6

Media

0.5

1.8

2.3

Travel & Leisure

2.1

2.1

Oil & Gas Producers

1.1

0.8

1.9

Technology Hardware & Equipment

1.6

1.6

 

The financial information for the period ended 31 May 2013 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

18 June 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMVFRLGFZM
Date   Source Headline
2nd May 20123:35 pmRNSDirector/PDMR Shareholding
1st May 201212:46 pmRNSCompany Secretary Change
1st May 201212:44 pmRNSListing Rule 15.5.1(4)
17th Apr 201210:03 amRNSNet Asset Value(s)
15th Mar 201212:02 pmRNSNet Asset Value(s)
17th Feb 20127:00 amRNSNet Asset Value(s)
6th Feb 201210:46 amRNSDirector/PDMR Shareholding
12th Jan 20129:40 amRNSNet Asset Value(s)
3rd Jan 20127:00 amRNSDirectorate Change
19th Dec 20119:28 amRNSInterim Management Statement
15th Dec 20113:50 pmRNSNet Asset Value(s)
7th Dec 20116:02 pmRNSDirector Declaration
24th Nov 20112:52 pmRNSChange of Name of Joint Manager
24th Nov 201110:03 amRNSHolding(s) in Company
14th Nov 20111:29 pmRNSNet Asset Value(s)
12th Oct 20119:49 amRNSNet Asset Value(s)
19th Sep 201110:41 amRNSHalf Yearly Report
14th Sep 20113:05 pmRNSDirector/PDMR Shareholding
13th Sep 201112:32 pmRNSNet Asset Value(s)
8th Sep 20111:45 pmRNSHalf Yearly Report
16th Aug 20119:30 amRNSDirector/PDMR Shareholding
15th Aug 20119:53 amRNSTransactions in a Close Period
15th Aug 20119:49 amRNSNet Asset Value(s)
28th Jul 20112:53 pmRNSGrant of Options
11th Jul 20112:28 pmRNSNet Asset Value(s)
7th Jul 20119:16 amRNSAdditional Listing
30th Jun 20112:39 pmRNSResult of AGM
27th Jun 201111:10 amRNSHolding(s) in Company
20th Jun 20119:44 amRNSInterim Management Statement
16th Jun 20119:23 amRNSHolding(s) in Company
9th Jun 20112:49 pmRNSNet Asset Value(s)
1st Jun 201110:33 amRNSAnnual Financial Report
24th May 201112:26 pmRNSFinal Results
11th May 20111:18 pmRNSNet Asset Value(s)
18th Apr 20115:26 pmRNSNet Asset Value(s)
6th Apr 20119:39 amRNSTransaction in Own Shares - Replacement
5th Apr 201112:27 pmRNSTransaction in Own Shares
4th Apr 20119:29 amRNSTransaction in Own Shares
28th Mar 20119:35 amRNSTransaction in Own Shares - Replacement
28th Mar 20119:05 amRNSTransaction in Own Shares
25th Mar 20117:00 amRNSTransactions in Close Period
10th Mar 201110:15 amRNSNet Asset Value(s)
28th Feb 20119:12 amRNSNet Asset Value(s) - Replacement
10th Feb 201111:34 amRNSNet Asset Value(s)
12th Jan 20119:47 amRNSNet Asset Value(s)
15th Dec 20103:45 pmRNSInterim Management Statement
10th Dec 20104:51 pmRNSTransaction in Own Shares
10th Dec 20104:49 pmRNSDirector/PDMR Shareholding
10th Dec 20109:23 amRNSNet Asset Value(s)
9th Nov 201011:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.